Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$5.42M Sell
23,416
-70,451
-75% -$14.3M 0.36% 72
2025
Q2
$17.4M Buy
+93,867
New +$17.4M 0.66% 20

Other funds holding ABBV

Point72 (DIFC)'s ABBV Position: Q3 2025 in Review

Point72 (DIFC) reduced its AbbVie (ABBV) stake by 75% in Q3 2025, selling an estimated $14.3M and leaving 23,416 shares worth $5.42M. The position accounts for 0.36% of the portfolio, ranked #72.

Point72 (DIFC) first reported a position in ABBV in Q2 2025 and has held it in 2 quarters since. The position peaked at $17.4M in Q2 2025. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Point72 (DIFC) held 23,416 shares of AbbVie worth $5.42M as of Q3 2025.
  • Point72 (DIFC) sold 70,451 AbbVie shares in Q3 2025, an estimated $14.3M.
  • AbbVie made up 0.36% of Point72 (DIFC)'s portfolio in Q3 2025, its #72 holding.
  • Point72 (DIFC) first reported a position in AbbVie in Q2 2025 and has held it in 2 quarters since.
  • Point72 (DIFC)'s AbbVie position peaked at $17.4M in Q2 2025.
  • 3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.